| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0006300 | Intron-Intron | chr20:35147428-35148843 | chr20:36519025-36520440 | 1416 nt | 0.4407 |
| hsa_DLGAP4_0006400 | Exon-Exon | chr20:35152653-35154409 | chr20:36524250-36526006 | 248 nt | 0.5685 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].